George Washington University
Dermatology residency · Washington, DC · Program website
- 2
- Faculty
- 7
- Trainees
- 273
- Papers
- 43%
- Trainees published
- 21%
- First author
3 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 273 in all. Updated 2026-11-07.
- Lifestyle-Driven Phenotypes in Sensitive Skin: A Cross-Sectional, Multicenter Study Across Urbanization TiersJade Conway et al. · Dermatology and Therapy · 2026 · PubMed
- Remibrutinib for Refractory Dissecting CellulitisTeresa Duong et al. · JAAD Case Reports · 2026
- INDIVIDUAL ARTICLE: Cutaneous and Systemic Adverse Events Associated With Topical Corticosteroid Use: A Targeted Literature ReviewAdam Friedman et al. · Journal of Drugs in Dermatology · 2026 · PubMed
- Beyond the Brain: Understanding the Dermatologic Associations of Neurodegenerative DiseasesAriana Zarghami et al. · Journal of Drugs in Dermatology · 2026 · PubMed
- Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert OpinionBenjamin Ungar et al. · Journal of Drugs in Dermatology · 2026 · PubMed
- INDIVIDUAL ARTICLE: Topical Corticosteroid Approved Labeling in the US: A Modern Inter- and Intra-Product AnalysisAdam Friedman et al. · Journal of Drugs in Dermatology · 2026 · PubMed
- INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting SystemAdam Friedman et al. · Journal of Drugs in Dermatology · 2026 · PubMed
- Low-Dose Oral Minoxidil Use for Pediatric Hair DisordersYagiz Matthew Akiska et al. · JAMA Dermatology · 2026 · PubMed
- Patient Experience and Preferences for Treatments in Atopic DermatitisDiego Ruiz Dasilva et al. · Dermatology and Therapy · 2026 · PubMed
- Can't Believe It Can Be Cryo'd: Beyond Conventional Applications of Liquid NitrogenAmreen Khakh et al. · Journal of Drugs in Dermatology · 2026 · PubMed
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 4 of 7 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
43%
of trainees have published
3rd of 5 dermatology residency programs with complete rosters
2.92
papers per trainee-year
1st of 5 dermatology residency programs with complete rosters
21%
of authorships as 1st author
4th of 5 dermatology residency programs with complete rosters
52%
of trainee papers with program faculty
1st of 5 dermatology residency programs with complete rosters
52
papers with a trainee author
1st author
11 · 21%
2nd author
16 · 31%
3rd author
6 · 12%
Middle
18 · 35%
Last author
1 · 2%
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
1 / 2
faculty matched
44 (44–44)
faculty h-index, median (IQR)
0
median FWCI (before 2025)
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Adam Friedman, MD | Dermatology and Skin Diseases; Acne and Rosacea Treatments and Effects | 44 | 237 | 20 | 165 | 0 |
| Emily Murphy, MD (unresolved) | — | — | 0 | 0 | 0 | — |
7 trainees are counted above but never listed by name.
About George Washington Universityinstitution-wide dermatology research
Dermatology publications from George Washington University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
148
works per year
4th of 58 dermatology residency programs
+7.0%
2-year growth
32nd of 58 dermatology residency programs
23.3%
in top 10% of field (works before 2025)
12th of 50 dermatology residency programs
43.5%
cited above world average
13th of 50 dermatology residency programs
Works per year · * 2026 so far
Dermatology · 707
Dermatology research topics at George Washington University
Papers in the window; each links to the list on OpenAlex.
- Dermatology and Skin Diseases 501
- Contact Dermatitis and Allergies 55
- Acne and Rosacea Treatments and Effects 43
- Hidradenitis Suppurativa and Treatments 34
- Dermatologic Treatments and Research 14
- Dermatological and COVID-19 studies 11
- Cutaneous lymphoproliferative disorders research 10
- Skin Protection and Aging 8
Most cited at George Washington University since 2024
All dermatology papers there on OpenAlex
- Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trialsJonathan I. Silverberg et al. · The Lancet · 2024 · PubMed · cited 171
- Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitisJonathan I. Silverberg et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · PubMed · cited 111
- Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsJonathan I. Silverberg et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 111
- Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)Jonathan I. Silverberg et al. · British Journal of Dermatology · 2024 · PubMed · cited 70
- Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of ExposureEric Lawrence Simpson et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 57
- A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter K. Haag et al. · British Journal of Dermatology · 2024 · PubMed · cited 55
- Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trialEric Lawrence Simpson et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 51
- The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trialsJonathan I. Silverberg et al. · Nature Communications · 2024 · PubMed · cited 49
- Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown OriginShawn G. Kwatra et al. · JAMA Dermatology · 2024 · PubMed · cited 49
- Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I. Silverberg et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 48